Dihydroergocristine Mesilate

Ergot alkaloid with dopaminergic effect used as a peripheral vasodilator in cerebral vascular insufficiency, mental deterioration and vertiginous syndrome. Oral, intramuscular or intravenous administration. 

At the date of the last update, we found no published data on its excretion in breast milk.

Its pharmacokinetic data (very large volume of distribution and moderately high molecular weight) make it unlikely to pass into breast milk in clinically significant quantities.

As a dopaminergic agonist, it inhibits prolactin and suppresses lactation. ^{(Aloysio 1988)}

It is a non-essential medication, of low therapeutic level ^{(SEFAP 2012, INSALUD 2001)}, with frequent and important side effects; perfectly dispensable.

See below the information of this related product:

• Ergot Fungus (Very unsafe. Contraindicated. Use of an alternative or cessation of breastfeeding. Read the Commentary.)